![Katharine Peterson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 37 689 $ as of 31/08/2026
Katharine Peterson currently works at Acrivon Therapeutics, Inc., as Vice President-Finance & Accounting from 2022.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/08/2026 | 18,033 ( 0.04% ) | 37 689 $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/06/2022 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 1 |
|---|---|
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
